News

cannabis use disorder marijuana joint weed smoking

Many states have legalized the recreational use of marijuana in recent years, creating one of the more radical cultural shifts the United States has seen in quite some time. What could this trend mean from a cardiologist's perspective? 

Interview with Nehal Mehta, MD, University of Pennsylvania, who explains how coronary inflammation can be seen using AI on cardiac CT scans to better risk stratify patients and begin preventive drug therapy.

The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation. 

Jeff Kuvin, MD, explains the effort to create an new independent cardiology board. He is the ACC point person for the effort.

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

doctor examines patient data on their tablet

Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.

Hēlo PE Thrombectomy System developed by U.S. medical device company Endovascular Engineering.

The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.

Interventional cardiologist James B. Hermiller, MD, is officially the new president of the Society for Cardiovascular Angiography & Interventions (SCAI) form 2024-2025. #SCAI #SCAI24 #SCAI2024.

Interventional cardiologist James B. Hermiller, MD, officially assumed the position at the end of SCAI 2024 Scientific Sessions.

offender-trouble-handcuffs-police-arrest-2102488.jpg

The 61-year-old physician is currently in jail. He was previously in the news for allegedly implanting stents that were not medically necessary, agreeing to pay a hefty sum to settle.

The DurAVR TAVR system from Anteris Technologies. A new biomimetic transcatheter aortic valve replacement (TAVR) system from Anteris Technologies could provide cardiologists with a new way to treat severe aortic stenosis (AS), according to new one-year data presented at SCAI 2024 Scientific Sessions, the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI). The DurAVR TAVR system, made from a single piece of anti-calcification ADAPT tissue patented by Anteris.

One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

The SPYRAL HTN-ON MED renal denervation trial failed to show that renal denervation was superior to sham control at improving ambulatory blood pressure (ABPM), but that might have been due to patient lifestyle changes during COVID-19.

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

The American Society of Echocardiography (ASE) launched its new, interactive EchoGuide mobile and web application for healthcare professionals last week, and the society said it already has about 15,000 downloads.

The ASE launched its new, interactive EchoGuide mobile and web application, and already has about 15,000 downloads.

Pulmonary hypertension (PAH) is usually treated with medication, but the more a patient has to pay for medications, the less likely they are to take them and become noncompliant. This was the finding of a new study showing how copayments may be a barrier to patients taking prostanoids and combination therapy for PAH.

The more a patient has to pay for medications, the less likely they are to take them. This was the finding of a new study showing how copayments may be a barrier to drugs to treat pulmonary arterial hypertension.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.